4,4,5,5-Tetramethyl-2-(5-methylthiophen-2-yl)-1,3,2-dioxaborolane, 95.0%, 1g

5-HYDROXY-2-(((TETRAHYDRO-2H-PYRAN-2-YL)OXY)METHYL)-4H-PYRAN-4-ONE, 95.0%, 250mg

2-(2,6-Dichlorophenoxy)ethan-1-amine hydrochloride, 10g

Methyl 2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate hydrochloride, 95%, 25g

(5-Chloropyridin-3-yl)boronic acid, 95.0%, 1g

2-Methyl-1-trifluoromethyl-propylamine, 98.0%, 250mg

5-Iodo-1-methyl-1H-imidazole, 95.0%, 1g

9-(2-Hydroxyethyl)adenine>98.0%(HPLC)(T)5g

(R)-3-((2S,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, 95+%, 25mg

(6-Bromopyridin-3-yl)methanamine, 95.0%, 5g

4-diméthylamino-2-méthoxybenzaldéhyde, min 98 %, pour la biochimie, 5 g, emballage en verre

4-((3-(aminomethyl)pyridin-2-yl)oxy)cyclohexan-1-one oxalate, 95.0%, 1g

(5-Pyrimidinylethynyl)trimethylsilane, 95.0%, 5g